Related Experiment Video
Updated: May 17, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left atrial appendage exclusion for stroke prevention in atrial fibrillation
Taral K Patel1, Clyde W Yancy, Bradley P Knight
1Division of Cardiology, Department of Internal Medicine, Feinberg School of Medicine, Northwestern University, 251 East Huron Street, Feinberg 8-503E, Chicago, IL 60611, USA.
Insights
Atrial fibrillation (AF) increases stroke risk. New mechanical left atrial appendage (LAA) exclusion devices offer an alternative to oral anticoagulation for stroke prevention in high-risk patients.
Area of Science:
- Cardiology
- Medical Devices
- Public Health
Background:
- Atrial fibrillation (AF) poses a significant and growing public health challenge, with a fivefold increase in stroke risk.
- Thromboembolic stroke prevention is paramount in AF management, with current treatments relying on oral anticoagulation.
- Limitations and challenges associated with oral anticoagulation necessitate alternative stroke prevention strategies.
Purpose of the Study:
- To review recent advancements in mechanical left atrial appendage (LAA) exclusion for stroke prevention in AF patients.
- To explain the rationale behind LAA exclusion, particularly for patients unsuitable for oral anticoagulation.
- To highlight promising LAA exclusion devices and discuss future directions in the field.
Main Methods:
- Summary of the public health impact of AF and stroke.
- Explanation of the role of the LAA in AF-related thromboembolism.
- Review of the historical context and current state of LAA exclusion devices.
Main Results:
- The LAA is a primary source of emboli in AF, making its exclusion a viable stroke prevention strategy.
- Mechanical LAA exclusion devices represent a promising alternative to oral anticoagulation.
- Several promising LAA exclusion devices are currently available, with ongoing development.
Conclusions:
- Mechanical LAA exclusion is an emerging and effective strategy for stroke prevention in atrial fibrillation.
- This approach is particularly beneficial for patients who cannot tolerate or are unsuitable for oral anticoagulation.
- Continued innovation in LAA exclusion devices holds significant promise for improving patient outcomes.
Abstract:
The public health burden of atrial fibrillation (AF) and associated thromboembolic stroke continues to grow at alarming rates. AF leads to a fivefold increase in the risk of stroke. Therefore, stroke prevention remains the most critical aspect of AF management. Current standard of care focuses on oral systemic anticoagulation, most commonly with warfarin and now with newer agents such as dabigatran, rivaroxaban, and apixaban. However, the challenges and limitations of oral anticoagulation have been well documented. Given the critical role of the left atrial appendage (LAA) in the genesis of AF-related thromboembolism, recent efforts have targeted removal or occlusion of the LAA as an alternative strategy for stroke prevention, particularly in patients deemed unsuitable for oral anticoagulation. This paper highlights recent advances in mechanical exclusion of the LAA. The problem of AF and stroke is briefly summarized, followed by an explanation for the rationale behind LAA exclusion for stroke prevention. After briefly reviewing the history of LAA exclusion, we highlight the most promising LAA exclusion devices currently available. Finally, we discuss future challenges and opportunities in this growing field.
